Underuse of evidence-based treatment partly explains the worse clinical outcome in diabetic patients with acute coronary syndromes
Authors:
- Shaun G. GoodmanSGShaun G. Goodman
- 1 October 2006
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 152 (4) , 676-683
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Standards of Medical Care in DiabetesDiabetes Care, 2005
- Presentation, management, and outcomes of diabetic patients compared to non-diabetic patients admitted for acute coronary syndromesHeart, 2004
- One-year outcome of patients after acute coronary syndromes (from the Canadian Acute Coronary Syndromes Registry)The American Journal of Cardiology, 2004
- A Validated Prediction Model for All Forms of Acute Coronary SyndromeJAMA, 2004
- Short- and long-term results after multivessel stenting in diabetic patientsJACC, 2004
- Under utilisation of evidence-based treatment partial explanation for the unfavourable prognosis in diabetic patients with acute myocardial infarctionEuropean Heart Journal, 2003
- Diabetic Retinopathy Should Not Be a Contraindication to Thrombolytic Therapy for Acute Myocardial Infarction: Review of Ocular Hemorrhage Incidence and Location in the GUSTO-I Trial fn1fn1This study was supported by Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genentech, South San Francisco, California; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.JACC, 1997
- A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery DiseaseNew England Journal of Medicine, 1997
- Influence of Diabetes Mellitus on Clinical Outcome in the Thrombolytic Era of Acute Myocardial Infarction fn1fn1The GUSTO-I study was supported by a combined grant from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genetech, South San Francisco, California; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.JACC, 1997
- Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patientsThe Lancet, 1994